Fractal shareholders raise $172 mn in pre-IPO secondary deal
ADVERTISEMENT Earlier, Fractal raised USD 685 million in funding from investors like TA, TPG and Apax, according to market research firm Tracxn.
"The total amount raised is USD 172 million at a valuation of USD 2.44 billion. The entire transaction is secondary in nature. No funds have come into Fractal," the source said.
The query sent to the company did not elicit any reply.
The majority of shares were sold by Apax Partners.
The secondary sale took place amid the company's plan to file draft papers with Sebi for an initial public offer. PTI
(You can now subscribe to our ETMarkets WhatsApp channel)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Healthcare Gets Its ESG Scorecard: New Framework to Guide Sustainable Investing in India's $596 Billion Sector
New Delhi: India's rapidly expanding healthcare and pharmaceutical sector has taken a decisive step toward sustainability and ethical investment with the launch of its first dedicated ESG framework. Developed by Aspire Impact in collaboration with Aspire Circle, the framework was unveiled in New Delhi and co-authored by 15 leading figures from across the healthcare value chain — including Fortis, Apollo, Cipla, Zydus, Sun Pharma, Redcliffe Labs, Quadria Capital, HealthQuad, and Tata Capital Healthcare Fund. Titled Healthcare: An ESG Performance Framework, the publication is part of Aspire's Capgemini-supported Impact Future Project and offers a structured roadmap for evaluating ESG performance in a sector expected to reach USD 596 billion by 2025. Despite its scale and critical role in public health, India's healthcare sector comprises only 6 percent of the market capitalization of the top 1,000 NSE-listed companies, highlighting an urgent need for standardized ESG benchmarks to guide responsible investment. Its a dual-rating system that separately assesses ESG risks and opportunities. It introduces 80 sector-agnostic and 27 sector-specific indicators to help stakeholders measure everything from biomedical waste management and antimicrobial resistance to green hospital infrastructure, ethical supply chains, and digital health adoption. The framework also features impact-oriented metrics such as WHO medicine prequalification, access to government health schemes, and AMR management systems. Amit Bhatia, Founder of Aspire Impact and Aspire Circle, described the framework as a catalyst for change in a sector that now needs to move beyond compliance. 'India's $310 billion healthcare and pharma sector can lead the world not just in treating illnesses, but in addressing social and environmental risks. Our ESG framework introduces measurable, comparable benchmarks that enable ethical, inclusive, and future-ready growth,' he said. From an investment perspective, the launch marks a shift toward data-driven ESG evaluation that goes beyond narrative sustainability claims. 'For investors and operators alike, this framework fills a critical gap. It empowers the entire ecosystem to act with greater confidence and accountability,' said Rahul Agarwal, Partner, HealthQuad. Anurag Pratap, CSR Leader,Capgemini India's emphasising the framework also has a wider societal impact,said, 'India's healthcare sector is growing rapidly, but growth without responsibility is a missed opportunity. This framework brings clarity to ESG efforts and enables institutions to align patient care with climate action, equitable access, and long-term resilience.' The framework is the third in a 12-part series released by Aspire Impact, with earlier reports focusing on core ESG KPIs and the financial services sector. Aspire also announced plans to launch IKOOWorld, a digital platform aimed at enabling both self-guided and assured ESG assessments. As India's healthcare ecosystem continues to digitise, scale, and diversify, this new ESG framework is expected to play a key role in shaping the future of sustainable healthcare investment , offering both accountability and ambition in equal measure.
Economic Times
2 hours ago
- Economic Times
Wipro Q1 Preview: PAT may rise 5-12% YoY; topline likely to remain muted. Key metrics to track
Wipro is expected to post muted Q1FY26 revenue growth due to weak demand in Europe, while PAT may rise 5–12% year-on-year. Margins are likely stable, supported by cost control. Analysts focus on H2 guidance, deal ramp-ups, and Europe's performance as key triggers. Tired of too many ads? Remove Ads Here's a breakdown of what analysts expect across six key metrics: PAT (Profit After Tax) Elara Capital pegs adjusted PAT at Rs 3,351 crore, up 10.3% YoY and down 6.6% QoQ. JM Financial estimates PAT at Rs 3,350 crore, growing 11.6% YoY but falling 6.1% QoQ. Kotak Equities is slightly lower with a Rs 3,309 crore estimate, implying 10.2% YoY growth and a 7.3% QoQ decline. HSBC, however, sees a sharper 11.4% QoQ dip, projecting PAT at Rs 3,161 crore—still a 5.3% YoY increase. Tired of too many ads? Remove Ads Revenue Elara Capital forecasts revenue at Rs 22,015 crore, up 0.2% YoY and down 2.2% QoQ. HSBC has a near-identical estimate of Rs 22,000 crore. JM Financial is slightly more optimistic at Rs 22,358 crore, up 1.8% YoY and down 0.6% QoQ. Kotak projects the lowest figure at Rs 21,991 crore, up 0.2% YoY and down 2.4% QoQ. EBIT / EBIT Margins Elara: Rs 3,781 crore, up 4.8% YoY, down 3.3% QoQ Rs 3,781 crore, up 4.8% YoY, down 3.3% QoQ HSBC: Rs 3,702 crore, up 2.1% YoY, down 4.7% QoQ Rs 3,702 crore, up 2.1% YoY, down 4.7% QoQ JM Financial: Rs 3,719 crore, up 2.5% YoY, down 4.3% QoQ Rs 3,719 crore, up 2.5% YoY, down 4.3% QoQ Kotak: Rs 3,847 crore, up 6.7% YoY, down 1.6% QoQ Kotak forecasts EBIT margin at 17.5%, up 106 bps YoY and 14 bps QoQ. HSBC sees 16.8%, up 31 bps YoY but down 44 bps QoQ. JM Financial believes margin stability will be supported by Wipro's efficiency programs and currency tailwinds. Growth Guidance JM Financial expects Wipro to be at the upper end of this band, thanks to a 135-bps cross-currency tailwind that could lift USD revenue by 0.7% QoQ. For Q2FY26, JM expects new guidance in the range of -1% to +1% QoQ cc growth, signaling potential stabilization in the second half of FY26. Kotak forecasts a 2.7% revenue decline, aligning with the midpoint of Wipro's guidance. Deals Key Monitorables Performance in Europe, which continues to weigh on overall growth Participation and competitiveness in vendor consolidation deals GCC (Global Capability Center) growth strategy Management commentary on margin sustainability and hiring trends Tier-1 IT services company Wipro will announce its Q1 earnings on Thursday, July 17. The company is expected to post soft revenue growth due to continued demand weakness in key markets like Europe and challenges in client budgets. However, brokerages project stable margins , supported by cost control and currency after tax ( PAT ) is expected to grow 5–12%, estimated in the range of Rs 3,161 crore to Rs 3,351 crore. Meanwhile, revenue growth may remain flat to 2% year-on-year in the April–June quarter, with estimates ranging between Rs 21,991 crore and Rs 22,358 from four brokerages—Elara Capital, JM Financial , Kotak Institutional Equities, and HSBC—have been taken into expect Wipro's net profit to remain resilient on a year-on-year basis, despite sequential sequential decline in profits is attributed to weaker revenues and some operating cost pressures during the performance is expected to be largely flat, with marginal YoY growth and QoQ declines across all estimates:HSBC expects a 1% decline in dollar revenues, noting that lower utilisation and a stronger rupee may weigh on revenue profit (EBIT) is expected to remain steady with moderate YoY gains, but flat to slightly negative QoQ performance:Wipro had earlier guided for a -3.5% to -1.5% QoQ constant currency (cc) revenue ramp-up of large deals, such as the Phoenix contract, is expected to support revenues in believe that while Q1FY26 may be muted, commentary and visibility into H2 will be critical. Key factors to watch include:(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)
&w=3840&q=100)
Business Standard
2 hours ago
- Business Standard
Ind, US inflation data hint downward bias on dollar-rupee forward premiums
Cooling inflation in India and tariff-induced price pressures in the US are cementing a downward bias on dollar-rupee forward premiums, according to analysts. India's retail inflation hit a six-year low in June, while US consumer prices rose at their fastest pace since February, with higher goods costs hinting at tariff effects. This divergence is likely to persist. Economists project India's consumer price index inflation to touch a record low in July, while the tariff impact is seen becoming more pronounced in the US inflation prints for July and August. Cooling domestic inflation is prompting calls for at least one more interest rate cut by the Reserve Bank of India, while analysts believe the rising US price pressures due to tariffs may keep the Federal Reserve from cutting rates. BofA Global Research sees no Fed rate cuts in 2025 and urges investors to "fade" the 2025 easing priced in. Markets currently expect just under two cuts this year. Diverging rate outlooks for the two central banks, shaped largely by the contrasting inflation trajectories, would put the squeeze on dollar-rupee forward premiums, which reflect the US-India interest rate differential. "The odds of another rate cut have increased in India and inflation will likely fall below 2 per cent in July, so these bets will rise going into the August meeting. This could keep USD/INR forward premia under stress," ANZ forex and rate strategist Dhiraj Nim said. On Wednesday, dollar-rupee forward premiums were a tad lower, with the one-year implied yield down 2 basis points at 1.96 per cent. The odds of US rate cuts are "going lower, while India's rate cut chances are rising. This builds the case for 1-year to be squeezed lower to 1.90 per cent," a swap trader at a mid-sized private bank said. The rupee, meanwhile, was modestly higher at 85.78 per dollar, comforted by broad-based interbank dollar sales.
